Franz Obermayr
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Franz Obermayr
Franz Obermayr was last confirmed as CEO at Kiora Pharmaceuticals Inc (KPRX) in a filing dated April 30, 2021. The proxy statement of Kiora Pharmaceuticals Inc reports total compensation of $581,457 for Franz Obermayr in fiscal 2021, including a base salary of $287,958. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2021-04-30
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Kiora Pharmaceuticals Inc (KPRX) | Former Acting Chief Executive Officer; former EVP Clinical Development | $287,958 | $581,457 |
| 2020 | Kiora Pharmaceuticals Inc (KPRX) | Former Acting Chief Executive Officer; former EVP Clinical Development | $8,476 | $8,476 |
Recent activity
No call appearances or filed executive changes recorded yet.